March 04, 2021
•
1 min read
CFA Asks for Pre-Market Safety Review, Accurate Labeling on Cell-Cultured Seafood Products

CFA submitted the following comments in response to the U.S. Food and Drug Administration’s (“FDA”) request for comments regarding cell-cultured or “lab grown” food products derived from seafood. The comments acknowledge that cell-cultured products, if made affordable and shown to be safe, could help to address important challenges in the food system. However, accurate and accessible labeling, as well as a comprehensive and transparent pre-market safety review, will serve a critical role in establishing consumer trust.
Our Subject Matter Experts

Thomas Gremillion
Director of Food Policy
Testimonies & Comments

Consumer Groups Oppose Addition of Segway Language Until Hearing on Safety Issues

CFA Opposes McConnell Medical Malpractice Amendment

Letter to President Bush on HHS Study of Medical Malpractice Insurance Rates
